STAB - Statera Biopharma's (STAB) CEO Michael K. Handley on Q3 2021 Results - Earnings Call Transcript
Statera Biopharma Inc. (STAB) Q3 2021 Earnings Conference Call November 15, 2021 5:30 PM ET Company Participants Nichol Ochsner – Executive Vice President-Investor Relations Michael K. Handley – President and Chief Executive Officer Peter Aronstam – Chief Financial Officer Taunia Markvicka – Chief Operating Officer Conference Call Participants Presentation Operator Good morning, ladies and gentlemen, and thank you for joining us for Statera Biopharma Inc's Third Quarter 2021 Financial Results Conference Call. Following the prepared remarks from the company, we will open the call for questions. I would now like to turn the call over to Statera's Executive Vice President of Investor Relations, Nichol Ochsner. Ma'am, you may now begin. Nichol Ochsner Good afternoon everyone and thank you for joining the Statera Biopharma's 2021 third quarter financial results and corporate update call. Earlier this afternoon, Statera Biopharma issued a press release detailing the financial results for the three and nine
For further details see:
Statera Biopharma's (STAB) CEO Michael K. Handley on Q3 2021 Results - Earnings Call Transcript